Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.6K

Structure of the human autophagy initiating kinase ULK1 in complex with potent inhibitors

Michael B Lazarus1, Chris J Novotny, Kevan M Shokat

  • 1Howard Hughes Medical Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco , San Francisco, California 94158, United States.

ACS Chemical Biology
|January 1, 2015
PubMed

Insights

Researchers determined the structures of ULK1 kinase, a key initiator of autophagy, alongside its inhibitors. This provides a foundation for developing new cancer therapeutics targeting the autophagy pathway.

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Molecular Medicine

Background:

  • Autophagy is a fundamental cellular process crucial for energy homeostasis and quality control.
  • Dysregulation of autophagy is implicated in various diseases, notably cancer.
  • ULK1 kinase is a critical initiator of the autophagy pathway, making it a therapeutic target.

Discussion:

  • This study presents the first reported structures of ULK1 in complex with potent inhibitors.
  • The unique structural features of ULK1 provide insights into its enzymatic activity.
  • Understanding these structures is crucial for developing targeted therapeutic strategies.

Key Insights:

  • The determined ULK1 structures reveal enzyme-specific characteristics.
  • These insights facilitate the rational design of selective ULK1 inhibitors.
  • The findings support the potential of targeting ULK1 for therapeutic interventions.

Outlook:

  • The structural data will guide the development of novel cellular probes.
  • This research opens avenues for designing potent and selective therapeutic agents targeting ULK1.
  • Further studies will explore the therapeutic efficacy of these inhibitors in disease models.

More Related Videos

Study of Protein-protein Interactions in Autophagy Research14:08

Study of Protein-protein Interactions in Autophagy Research

Published on: September 9, 2017

9.7K
A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.6K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
21.9K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.1K